BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8823611)

  • 1. Natural history of hydrops resolution in fetuses with tachyarrhythmias diagnosed and treated in utero.
    Petrikovsky B; Schneider E; Ovadia M
    Fetal Diagn Ther; 1996; 11(4):292-5. PubMed ID: 8823611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
    Parilla BV; Strasburger JF; Socol ML
    Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct, and transplacental therapy.
    Hallak M; Neerhof MG; Perry R; Nazir M; Huhta JC
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):523-5. PubMed ID: 1870815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
    Tunca Sahin G; Beattie RB; Uzun O
    Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
    Pete B; Hajdú J; Papp Z
    Orv Hetil; 2004 Dec; 145(52):2611-7. PubMed ID: 15724696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
    Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of intermittent tachyarrhythmias in the fetus.
    Simpson JM; Milburn A; Yates RW; Maxwell DJ; Sharland GK
    Pediatr Cardiol; 1997; 18(2):78-82. PubMed ID: 9049114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero conversion of supraventricular tachycardia with digoxin and procainamide at 17 weeks' gestation.
    Battiste CE; Neff TW; Evans JF; Cline BW
    Am J Perinatol; 1992 Jul; 9(4):302-3. PubMed ID: 1627225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonimmune fetal hydrops secondary to fetal tachycardia: their intrauterine diagnosis and treatment].
    Robert JA; Gormaz G; Heusser F; Urcelay G
    Rev Chil Obstet Ginecol; 1991; 56(6):464-8. PubMed ID: 1669556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
    Agarwal A; Saha SC; Kaur A; Naganur S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal supraventricular tachycardia refractory to digoxin cardioversion. A case report.
    Repke JT; Steinbach G
    J Reprod Med; 1986 Mar; 31(3):195-7. PubMed ID: 3701719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone in treatment of fetal supraventricular tachycardia. A case report and review of literature.
    Pradhan M; Manisha M; Singh R; Kapoor A
    Fetal Diagn Ther; 2006; 21(1):72-6. PubMed ID: 16354980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
    Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK
    Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric importance, diagnosis, and management of fetal tachycardias.
    Maxwell DJ; Crawford DC; Curry PV; Tynan MJ; Allan LD
    BMJ; 1988 Jul; 297(6641):107-10. PubMed ID: 3408929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report.
    Merriman JB; Gonzalez JM; Rychik J; Ural SH
    J Reprod Med; 2008 May; 53(5):357-9. PubMed ID: 18567282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia.
    Holmes S; Hornberger LK; Jaeggi E; Howley L; Moon-Grady AJ; Uzun O; Kaizer A; Gilicze O; Cuneo BF
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):552-557. PubMed ID: 37128167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia.
    Krapp M; Kohl T; Simpson JM; Sharland GK; Katalinic A; Gembruch U
    Heart; 2003 Aug; 89(8):913-7. PubMed ID: 12860871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete resolution of arrhythmia-induced hydrops fetalis in utero.
    Narayanan M; Dhuka S; Alapati S; Kauffman RP
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33040036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.